← Back to Search
Relationships Among Bleeding Severity, Health‐related Quality Of Life, And Platelet Count In Children With Immune Thrombocytopenic Purpura
C. Neunert, G. Buchanan, V. Blanchette, D. Barnard, N. Young, C. Curtis, R. Klaassen
Published 2009 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Important outcomes for children with immune thrombocytopenic purpura (ITP) include health‐related quality of life (HRQOL) and bleeding severity. A HRQOL instrument for children with ITP, the Kids' ITP Tools (KIT), was recently validated. Secondary analysis of the KIT database was performed to determine relationships among platelet count, bleeding severity and HRQOL. Bleeding severity grade correlated with platelet count in chronic ITP but not in acute ITP. Platelet count and bleeding severity failed to have any statistically significant correlations with the KIT scores. These findings suggest that relationships among outcome measures in children with ITP, using currently available instruments, remain poorly defined. Pediatr Blood Cancer 2009;53:652–654. © 2009 Wiley‐Liss, Inc.
This paper references
Management of childhood idiopathic thrombocytopenic purpura
J. Lilleyman (1999)
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
G. Buchanan (2002)
Development of Disease-Specific Health-Related Quality-of-Life Instruments for Children With Immune Thrombocytopenic Purpura and Their Parents
D. Barnard (2003)
Development of diseasespecific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents
D Barnard (2003)
Pediatr Blood Cancer
W. A. Abdullah (2004)
Quantitative Assessment of Drug Treatment Side Effects in Children with Idiopathic Thrombocytopenic Purpura (ITP).
G. Buchanan (2004)
Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools.
R. Klaassen (2007)
New thrombopoietic growth factors.
D. Kuter (2007)
A cost‐utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)
Sarah H. O'Brien (2007)
New thrombopoietic growth factors. Blood 2007;109: 4607–4616
DJ Kuter (2007)
Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: The Kids
RJ Klaassen (2007)
This paper is referenced by
Pediatric immune thrombocytopenia (ITP) treatment
T. Kim (2021)
Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia
J. Grainger (2021)
Quality of life is an important indication for second‐line treatment in children with immune thrombocytopenia
Kristin A Shimano (2021)
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol
Kristin A Shimano (2021)
IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP.
M. Carcao (2020)
Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life
A. Tantawy (2020)
The Cost-Effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States.
G. Tremblay (2020)
Measuring parent proxy-reported quality of life of 11 rare diseases in children in Zhejiang, China
Qisheng Gao (2020)
Fatigue, executive function and psychological effects in children with immune thrombocytopenia: a cross‐sectional study
S. Towner (2020)
A Narrative Approach to Describe QoL in Children With Chronic ITP
P. Giordano (2019)
Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi‐institutional review
T. Kim (2019)
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
C. Neunert (2019)
Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
R. Kohli (2019)
Immune thrombocytopenia: improving quality of life and patient outcomes
P. Trotter (2018)
Health-Related Quality of Life in Patients with Immune Thrombocytopenia
R. Klaassen (2018)
Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants
C. Bennett (2018)
Psychiatric Disorders and Quality of Life in Egyptian Patients with Chronic Immune Thrombocytopenic Purpura: A Single Center Study
S. Yahia (2018)
Patterns and influences in health‐related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort
A. Flores (2017)
When and how to treat childhood immune thrombocytopenia.
Jennifer Allen (2016)
I When and how to treat childhood immune
Health-related quality of life in children with chronic immune thrombocytopenia in China
Heng Zhang (2016)
Bleeding Associated with Thrombocytopenia
S. Sartain (2016)
Bleeding complications in immune thrombocytopenia.
D. Arnold (2015)
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
C. Neunert (2015)
Newly diagnosed immune thrombocytopenic purpura in childhood: successful implementation of a limited intervention strategy in the setting of pediatric emergency care.
B. Rohmer (2015)
The psychological profile of children with immune thrombocytopenia and the factors influencing well-being
Sarah Towner (2015)
Health-related Quality of Life of Egyptian Children With Immune Thrombocytopenia and Their Parents
G. Mokhtar (2014)
UvA-DARE ( Digital Academic Repository ) Pediatric immune thrombocytopenia : Catching platelets
Health-related quality of life in children with newly diagnosed immune thrombocytopenia
K. M. Heitink-Pollé (2014)
A review of the management of childhood immune thrombocytopenia: how can we provide an evidence‐based approach?
N. Cooper (2014)
ITP-QoL Questionnaire for Children with Immune Thrombocytopenia: Italian Version validation's
P. Giordano (2014)
The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP)
P. Basciano (2013)See more